|
TTC14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.63511434894781E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.44560055434806E-10 |
| Normal-vs-Stage2 |
2.26470000530554E-08 |
| Normal-vs-Stage3 |
5.61599655668488E-11 |
| Normal-vs-Stage4 |
1.5069299999948E-05 |
| Stage1-vs-Stage2 |
1.674170E-01 |
| Stage1-vs-Stage3 |
3.856900E-03 |
| Stage1-vs-Stage4 |
3.638600E-01 |
| Stage2-vs-Stage3 |
5.537400E-01 |
| Stage2-vs-Stage4 |
9.270200E-01 |
| Stage3-vs-Stage4 |
6.138800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.32187660396266E-12 |
| Normal-vs-AfricanAmerican |
6.814000E-04 |
| Normal-vs-Asian |
6.226900E-04 |
| Caucasian-vs-AfricanAmerican |
6.171800E-01 |
| Caucasian-vs-Asian |
4.590500E-02 |
| AfricanAmerican-vs-Asian |
4.190400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.77069999995894E-07 |
| Normal-vs-Female |
1.72384329033548E-12 |
| Male-vs-Female |
3.591800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.22280013576437E-10 |
| Normal-vs-Age(41-60Yrs) |
2.30550023516685E-10 |
| Normal-vs-Age(61-80Yrs) |
6.53010001627763E-09 |
| Normal-vs-Age(81-100Yrs) |
6.78939999998462E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.615000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.629370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.929900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.807800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.300100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.129200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.57899999987077E-07 |
| Classical-VS-Follicular |
8.870200E-01 |
| Classical-VS-Other |
7.821000E-01 |
| Classical-VS-Normal |
2.66619948341429E-10 |
| Tall-VS-Follicular |
1.560050E-04 |
| Tall-VS-Other |
6.978200E-02 |
| Tall-VS-Normal |
2.21156426505331E-13 |
| Follicular-VS-Other |
7.580800E-01 |
| Follicular-VS-Normal |
1.68130000033351E-07 |
| Other-VS-Normal |
4.144000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.53189724530989E-11 |
| Normal-vs-N1 |
2.604500E-03 |
| N0-vs-N1 |
2.866400E-01 |
|
|
